Old Web
English
Sign In
Acemap
>
authorDetail
>
Fengjie Shi
Fengjie Shi
Pharmacology
Angiotensin II
KEAP1
Medicine
Endothelial dysfunction
4
Papers
13
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DL-3-n-Butylphthalide Attenuates Myocardial Hypertrophy by Targeting Gasdermin D and Inhibiting Gasdermin D Mediated Inflammation.
2021
Frontiers in Pharmacology
Bingjiang Han
Jiajun Xu
Xiaowen Shi
Zhanxiong Zheng
Fengjie Shi
Fenfen Jiang
Jibo Han
Show All
Source
Cite
Save
Citations (0)
Occurrence and predictive risk factors associated with in-stent restenosis after drug-eluting stent implantation in diabetic patients: a prospective, clinical cohort study
2020
Sheng-Gang Zhao
Jian-Jiang Xu
Li-qin Jiang
Zhen-Liang Chu
An-Qian Tao
Lei Jin
Jibo Han
Bin Zhang
Zhanxiong Zheng
Fengjie Shi
Ran Zhang
Xiang Yu-zhang
Fen-Fen Jiang
Bing-Jiang Han
Show All
Source
Cite
Save
Citations (0)
Schisandrin C targets Keap1 and attenuates oxidative stress by activating Nrf2 pathway in Ang II-challenged vascular endothelium: Sch C prevents endothelial oxidative stress by targeting Keap1
2019
Phytotherapy Research
Jibo Han
Xiaowen Shi
Yao Du
Fengjie Shi
Bin Zhang
Zhanxiong Zheng
Jianjiang Xu
Liqin Jiang
Show All
Source
Cite
Save
Citations (6)
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway
2018
Drug Design Development and Therapy
Jibo Han
Xiaowen Shi
Zhanxiong Zheng
Bin Zhang
Fengjie Shi
Liqin Jiang
Jianjiang Xu
Show All
Source
Cite
Save
Citations (7)
1